Poulton Jeffrey V.
SEC insider (Form 3/4/5 filer). CIK 0001782962. Director at CervoMed Inc. (CRVO) and 1 other issuer. 105 reported Form 4/5 transactions since Sep 2024; latest on Jun 8, 2026. Located in BOSTON, MA.
Companies Poulton Jeffrey V. has filed insider reports for
- CervoMed Inc. (CRVO): Director
- ALNYLAM PHARMACEUTICALS, INC. (ALNY): Officer, EVP, Chief Financial Officer
Poulton Jeffrey V.
CIK: 0001782962
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (105 total)
- Jun 8, 2026CRVO
CervoMed Inc.
AwardDirectStock Option (Right to Buy)
8.2K shares- - Mar 4, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect291 shares at avg. $324.88$95K - Mar 4, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect230 shares at avg. $320.81$74K - Mar 4, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect374 shares at avg. $323.01$121K - Mar 4, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect818 shares at avg. $323.84$265K - Mar 4, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect223 shares at avg. $325.67$73K - Mar 4, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect114 shares at avg. $319.03$36K - Mar 4, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect109 shares at avg. $320.01$35K - Mar 4, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect309 shares at avg. $321.82$99K - Mar 2, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect541 shares at avg. $326.81$177K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 8, 2026 |  CRVO CervoMed Inc. | Award Stock Option (Right to Buy) | 8,150 | - | - | Direct |
| Mar 4, 2026 |  ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 291 | $324.88 | $94,540 | Direct |
| Mar 4, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 230 | $320.81 | $73,786 | Direct |
| Mar 4, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 374 | $323.01 | $120,806 | Direct |
| Mar 4, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 818 | $323.84 | $264,901 | Direct |
| Mar 4, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 223 | $325.67 | $72,624 | Direct |
| Mar 4, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 114 | $319.03 | $36,369 | Direct |
| Mar 4, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 109 | $320.01 | $34,881 | Direct |
| Mar 4, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 309 | $321.82 | $99,442 | Direct |
| Mar 2, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 541 | $326.81 | $176,804 | Direct |
1-10 of 105 transactions